Clover Health IPO

Clover Health is a health insurance company driving to improve the overall state of healthcare in America by integrating the company's systems with doctors, clinicians, and nurse practitioners to help healthcare professionals in the field intervene directly into patients’ wellness to help them avoid acute health episodes.

Register for Details

For more details on financing and valuation of private companies similar to Clover Health before its , register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn More About Clover Health

To invest in Clover Health pre-IPO

Can you invest in Clover Health pre-IPO?

You may invest in Clover Health as it is a public company listed on the NASDAQ with ticker CLOV. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Clover Health before it goes public?

You can no longer sell shares of Clover Health on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Clover Health shares?

Forge can no longer determine the value of Clover Health shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Clover Health a publicly traded company?

Clover Health became a public company following its SPAC on 01/08/2021 and is now traded on the NASDAQ under the ticker CLOV.

To learn more about Clover Health potential IPO

Will Clover Health go IPO?

Clover Health became a public company following its SPAC on 01/08/2021 and is now traded on the NASDAQ under the ticker CLOV.

What is Clover Health’s IPO price?

The IPO price of Clover Health is not currently available.

When was Clover Health founded?

Clover Health was founded in 2014.

What is Clover Health funding to date?

Clover Health has raised $676.33MM to date.

Clover Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
05/10/2017 Series D $130MM $xx.xx $1.23B Baillie Gifford, Expanding Capital, First Round Capital, Greenoaks Capital, Gv, Palm Drive Capital, Sequoia Capital, Toba Capital, Western Technology Investment
Price per Share
$xx.xx
Shares Outstanding
13,862,526
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Expanding Capital, First Round Capital, Greenoaks Capital, Gv, Palm Drive Capital, Sequoia Capital, Toba Capital, Western Technology Investment
05/23/2016 Series C $160.17MM $xx.xx $835MM Ame Cloud Ventures, Arena Ventures, Casdin Capital, First Round Capital, Floodgate Fund, Greenoaks Capital, Nexus Venture Partners, Refactor Capital, Sequoia Capital, Social Capital, Spark Capital, Wildcat Venture Partners
Price per Share
$xx.xx
Shares Outstanding
19,066,809
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ame Cloud Ventures, Arena Ventures, Casdin Capital, First Round Capital, Floodgate Fund, Greenoaks Capital, Nexus Venture Partners, Refactor Capital, Sequoia Capital, Social Capital, Spark Capital, Wildcat Venture Partners
01/05/2016 Series A-1 $7.5MM $xx.xx $78MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
7,199,261
Liquidation Pref Order
2
Liquidation Pref As Multiplier
3.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
01/05/2016 Series A $5.5MM $xx.xx $70.5MM Athyrium Capital Mgmt, First Round Capital, Nathaniel Turner, Oxeon Partners
Price per Share
$xx.xx
Shares Outstanding
5,274,468
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athyrium Capital Mgmt, First Round Capital, Nathaniel Turner, Oxeon Partners
12/16/2015 Series B $35MM $xx.xx $263MM Athyrium Capital Mgmt, First Round Capital, Sequoia Capital, Social Capital, Wildcat Venture Partners
Price per Share
$xx.xx
Shares Outstanding
10,338,818
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athyrium Capital Mgmt, First Round Capital, Sequoia Capital, Social Capital, Wildcat Venture Partners
Updated on: Dec 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.